Drug
AND017 clinical trials
- studies test it
- 10
- open now
- 6
- in phase 3
- 2
- first study started
- 2018
Keep track of what changes. Save the AND017 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
8 studies that test it; most in 2025 (3); 2 more planned to start later
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Kind Pharmaceuticals LLC (10)
Studies
Open first, then newest update. How each study uses AND017 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study of AND017 in Cancer Related Anemic Patients Receiving ChemotherapyNot yet recruitingPhase 2Kind Pharmaceuticals LLCNCT06075030Written as AND017
- A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving ChemotherapyNot yet recruitingPhase 2Kind Pharmaceuticals LLCNCT06075043Written as AND017
- A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With AnemiaRecruitingPhase 3Kind Pharmaceuticals LLCNCT07494409Written as AND017 capsules
- A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)RecruitingPhase 3Kind Pharmaceuticals LLCNCT07487727Written as AND017
- A Study of Safety and Efficiency of AND017 in Patients With β-thalassemiaRecruitingPhase 2Kind Pharmaceuticals LLCNCT06302491Written as AND017 capsules
- A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic SyndromeRecruitingPhase 2Kind Pharmaceuticals LLCNCT06304103Written as AND017
- A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on DialysisCompletedPhase 2Kind Pharmaceuticals LLCNCT05265325Written as AND017 capsules TIW
- A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) PatientsCompletedPhase 2Kind Pharmaceuticals LLCNCT05035641Written as AND017
- A Dose-escalation Study of AND017 in Healthy SubjectsCompletedPhase 1Kind Pharmaceuticals LLCNCT04751539Written as AND017 single dose
- A Food-Effect Study of AND017 in Healthy ParticipantsCompletedPhase 1Kind Pharmaceuticals LLCNCT04712500Written as AND017